Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-31 @ 1:13 PM
Study NCT ID:
NCT07317934
Status:
RECRUITING
Last Update Posted:
2026-03-05
First Post:
2025-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
Sponsor:
Innostellar Biotherapeutics Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
INNOSTELLAR-LX102A03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None